Xolair Interventional Study in ASD Patients With Comorbid Atopy

Clinical trial NCT04535817 · WITHDRAWN

Trial details

NCT number: NCT04535817
Sponsor: Beth Israel Deaconess Medical Center
Status: WITHDRAWN
Phase: Phase 1
Study type: INTERVENTIONAL

Autism Spectrum Disorder Atopy

Start date: 2021-01-01
Primary completion: 2022-01-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.